Campbell David Alan

Insider profile

Performance

Overall performance
1.0

Performance over holding periods
1.0
30 days 90 days 120 days
Average return -2% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
1 0% Buy
34 71% Buy
47 69% Buy
Campbell David Alan's trades of Janux Therapeutics Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2026-01-02 2026-01-02 S Sale
93,768 +10.0%
57.42
US$1,804,656
93,768 +10.0% 57.42 US$1,804,656
2025-01-08 2025-01-07 PlS Planned sale
38,981 +47.3%
41.72
US$2,563,666
38,981 +47.3% 41.72 US$2,563,666
2025-01-07 2025-01-07 PrS Proposed sale
73,840
244.02
US$4,259,654
73,840 244.02 US$4,259,654
2024-12-26 2024-12-26 PrS Proposed sale
25,000
56.19
US$1,404,805
25,000 56.19 US$1,404,805
2024-12-27 2024-12-24 PlS Planned sale
25,000 -10.3%
56.19
US$1,404,805
25,000 -10.3% 56.19 US$1,404,805
2024-12-03 2024-12-03 PlS Planned sale
15,000 -5.8%
67.00
US$1,005,000
15,000 -5.8% 67.00 US$1,005,000
2024-11-27 2024-11-25 PlS Planned sale
6,719 -2.5%
52.04
US$349,647
6,719 -2.5% 52.04 US$349,647
2024-11-27 2024-11-25 PlS Planned sale
18,281 -6.5%
51.43
US$940,232
18,281 -6.5% 51.43 US$940,232
2024-10-30 2024-10-28 PlS Planned sale
11,103 -3.8%
53.94
US$598,909
11,103 -3.8% 53.94 US$598,909
2024-10-30 2024-10-28 PlS Planned sale
13,897 -4.5%
53.22
US$739,650
13,897 -4.5% 53.22 US$739,650
2024-09-27 2024-09-27 PrS Proposed sale
90,000
48.33
US$4,350,000
90,000 48.33 US$4,350,000
2024-09-27 2024-09-27 PlS Planned sale
795 -0.3%
47.84
US$38,032
795 -0.3% 47.84 US$38,032
2024-09-27 2024-09-27 PlS Planned sale
5,248 -1.7%
46.86
US$245,895
5,248 -1.7% 46.86 US$245,895
2024-09-27 2024-09-27 PlS Planned sale
18,957 -5.7%
46.09
US$873,715
18,957 -5.7% 46.09 US$873,715